Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use As a Novel HIV-1 Vaccine

Even though the rate of new human immunodeficiency virus type 1 (HIV-1) infections is gradually decreasing worldwide, an effective preventive vaccine for HIV-1 is still urgently needed. The recombinant Mycobacterium bovis BCG (rBCG) is promising for the development of an HIV-1 vaccine. Recently, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Byoung-Jun, Kim, Bo-Ram, Kook, Yoon-Hoh, Kim, Bum-Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880907/
https://www.ncbi.nlm.nih.gov/pubmed/29636755
http://dx.doi.org/10.3389/fimmu.2018.00643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880907/
https://www.ncbi.nlm.nih.gov/pubmed/29636755
http://dx.doi.org/10.3389/fimmu.2018.00643

Ejemplares similares